Zydus Cadila Gets USFDA Nod to Market Ointment for Treating Skin Conditions

The company has received final approval from the United States Food and Drug Administration (USFDA) to market Betamethasone Dipropionate ointment USP 0.05 per cent, Zydus Cadila said in a statement.

from Top Business News- News18.com
Read The Rest:timesnownews...
Zydus Cadila Gets USFDA Nod to Market Ointment for Treating Skin Conditions Zydus Cadila Gets USFDA Nod to Market Ointment for Treating Skin Conditions Reviewed by Team Exprssnews on July 15, 2020 Rating: 5

No comments:

Powered by Blogger.